Phosphotransferases (Alcohol Group Acceptor)
- Name
- Phosphotransferases (Alcohol Group Acceptor)
- Accession Number
- DBCAT002920
- Description
A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.
- Drugs
Drug Drug Description Sitimagene ceradenovec Intended for the treatment of brain cancer. Nelipepimut-S Investigated for use/treatment in prostate cancer and breast cancer. Luspatercept An erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. Dalantercept Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma). VEGFR2-169 VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)). - Drugs & Drug Targets
Drug Target Type Nelipepimut-S HLA class I histocompatibility antigen, A-2 alpha chain target Nelipepimut-S HLA class I histocompatibility antigen, A-3 alpha chain target